Back to companies

AYTU BIOPHARMA, INC

AYTUUSNASDAQPharmaceuticals & Healthcare

AYTU BIOPHARMA, INC

Revenue
$57.6mn
YoY -13.3%
Operating income
-$8.3mn
FY2026
Employees
—
Founded
—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API